BlackRock, Inc. 13D and 13G filings for OptimizeRx Corporation:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-01-29 3:26 pm Purchase | 2023-12-31 | 13G | OptimizeRx Corporation OPRX | BlackRock Inc. BLK | 1,134,954 6.300% | 93,216 (+8.95%) | Filing |
| 2023-04-06 09:29 am Sale | 2023-03-31 | 13G | OptimizeRx Corporation OPRX | BlackRock Inc. BLK | 1,041,738 6.100% | -1,672,452 (-61.62%) | Filing |
| 2023-01-23 3:52 pm Purchase | 2022-12-31 | 13G | OptimizeRx Corporation OPRX | BlackRock Inc. BLK | 2,714,190 15.800% | 46,102 (+1.73%) | Filing |
| 2022-01-27 5:13 pm Unchanged | 2021-12-31 | 13G | OptimizeRx Corporation OPRX | BlackRock Inc. BLK | 2,668,088 15.000% | 0 (Unchanged) | Filing |
| 2022-01-26 09:16 am Purchase | 2021-12-31 | 13G | OptimizeRx Corporation OPRX | BlackRock Inc. BLK | 2,668,088 15.000% | 67,317 (+2.59%) | Filing |
| 2021-11-24 3:40 pm Unchanged | 2021-10-31 | 13G | OptimizeRx Corporation OPRX | BlackRock Inc. BLK | 2,600,771 14.800% | 0 (Unchanged) | Filing |
| 2021-11-10 09:43 am Purchase | 2021-10-31 | 13G | OptimizeRx Corporation OPRX | BlackRock Inc. BLK | 2,600,771 14.800% | 1,615,661 (+164.01%) | Filing |
| 2021-01-29 5:22 pm Purchase | 2020-12-31 | 13G | OptimizeRx Corporation OPRX | BlackRock Inc. BLK | 985,110 6.500% | 46,674 (+4.97%) | Filing |